Skip to main content

Medical Devices Testing Services Market Size Worth USD 22.43 Billion in 2032 | Emergen Research

The growing government initiatives on improving the healthcare infrastructure and improvement in medical device technology are driving the demand of the Medical Devices Testing Services Market

Vancouver, Nov. 15, 2023 (GLOBE NEWSWIRE) — The global Medical Devices Testing Services Market will be worth USD 22.43 Billion by 2032, according to a current analysis by Emergen Research. The growth of this market can be attributed to the growing government initiatives on improving the healthcare infrastructure. The increasing healthcare budgetary allocation in the emerging economies is expected to drive the demand for the medical devices testing services market.

The improvement in medical device technology has resulted in the increased efficiency of the devices and improved patient care, which in turn has increased the adoption of the testing services. Increasing development in the field of personalized medicine and the drug-device combination is most likely to fuel the demand for the testing services. Technological advancements such as the implementation of Artificial Intelligence or the Internet of Things in the testing services of the medical devices is expected to drive the growth of the market.

The presence of complicated reimbursement policies is expected to restrain the growth of the Medical Devices Testing Services market. Moreover, the rising cost of medical device testing services is projected to hamper the demand for testing services. 

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/365

Scope of Research

Report DetailsOutcome
Market size value in 2019USD 7.20 Billion
CAGR (2023 – 2032)9.5%
Revenue forecast in 2032USD 22.43 Billion
Base year for estimation2022
Historical data2019-2021
Forecast period2023-2032
Quantitative unitsVolume in Tons, Revenue in USD Thousand, and CAGR from 2023 to 2032
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments coveredPhase, Service, region
Regional scopeNorth America; Europe; Asia Pacific; Central & South America; MEA
Country scopeU.S.; Canada; Mexico; U.K.; Germany; France; Italy; Spain; China; India; Japan; South Korea; Brazil; Saudi Arabia; South Africa; Turkey
Key companies profiledSGS S.A., Toxikon, Inc., Intertek Group plc, Pace Analytical Services, Charles River Laboratories International, Inc., American Preclinical Services LLC, North American Science Associates, Inc., Sterigenics International LLC, Eurofins, and WuXi AppTec Group
Customization scope10 hrs of free customization and expert consultation

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/365

Major Companies and Competitive Landscape

The Medical Devices Testing Services Market is moderately fragmented with a large number of small and medium-sized manufacturers, which account for a major part of the global share. The manufacturers are well-equipped with manufacturing facilities and are involved in several research & development activities. Some of the prominent players in the Medical Devices Testing Services Market include:

  • SGS S.A.
  • Toxikon, Inc.
  • Intertek Group plc
  • Pace Analytical Services
  • Charles River Laboratories International, Inc.
  • American Preclinical Services LLC
  • North American Science Associates, Inc.
  • Sterigenics International LLC
  • Eurofins
  • WuXi AppTec Group

Strategic Development

In April 2019, SGS, the leading inspection, verification, testing, and certification company in the world, has entered into a joint venture with Allion Labs, which is a renowned Internet of Things testing service provider.

Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/365

Key Highlights from The Report

  • In June 2020, Intertek, a total quality assurance provider to industries worldwide, announced the expansion of its personal protective equipment services to include precertification testing of N95 respirators to requirements set by the National Institute for Occupational Safety and Health (NIOSH).
  •  The preclinical segment held the largest market share of 57.6% in 2019. Rising investments by the pharmaceutical companies to increase the efficiency of the testing services of the medical devices is expected to drive the growth of the segment.
  • The Microbiology & Sterility Testing segment is forecasted to grow with the fastest CAGR of 10.0% over the forecast period. The increasing research & development in life science research is expected to drive the growth of the segment.   
  • North America accounted for the second-largest market share of the Medical Devices Testing Services market in 2019 due to the presence of a technologically advanced healthcare system and the presence of major medical device companies in the region.
  • Key participants include SGS S.A., Toxikon, Inc., Intertek Group plc, Pace Analytical Services, Charles River Laboratories International, Inc., American Preclinical Services LLC, North American Science Associates, Inc., Sterigenics International LLC, Eurofins, and WuXi AppTec Group, among others.

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/medical-devices-testing-services-market   

Emergen Research has segmented the global Medical Devices Testing Services Market on the basis of Phase, Service, and region:

  • Phase Outlook (Revenue, USD Billion; 2019-2032)
    • Clinical
    • Preclinical (Medical Coatings and Antimicrobial Wound Dressings) 
  • Service Outlook (Revenue, USD Billion; 2019-2032)
    • Chemistry Test
    • Package Validation
    • Microbiology & Sterility Testing (Pyrogen and Endotoxin Testing, Anti-microbial Activity Testing, Sterility Test and Validation and Bio-Burden Determination)
    • Biocompatibility Tests
  • Regional Outlook (Revenue, USD Billion; 2019-2032)
    • North America
      1. U.S.
      2. Canada
    • Europe
      1. Germany
      2. UK
      3. France
      4. BENELUX
      5. Rest of Europe
    • Asia Pacific
      1. China
      2. Japan
      3. South Korea
      4. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • MEA
      1. Saudi Arabia
      2. UAE
      3. Rest of MEA

Curated Reports You Shouldn’t Miss: Dive In Now!

Newborn Screening Market Size, Share, Trends, By Technology (Tandem Mass Spectrometry, Pulse Oximetry, Enzyme Based Assay, DNA Assay, Electrophoresis), By Product (Instruments, Reagents, Assay Kits), By Application, Forecasts to 2027

RFID in Healthcare Market By Product (Tags, Systems & Software) and By Application (Asset Tracking, Patient Tracking, Pharmaceutical Tracking, Blood Tracking, Others), Forecasts to 2027

Next Generation Sequencing Market, By Product Type (Instruments, Reagents and Consumables, and Service), By Sequencing Type (Whole Genome and Others), By Application, By End-Use, and By Region Forecast to 2030

Regenerative Medicine Market, By Type (Gene Therapy and Cell Therapy), By Application (Oncology and Musculoskeletal Disorder), By End-User (Hospitals and Clinics, Specialty Centers, Government & Academic Research Institutes), and By Region Forecast to 2030

Patient Engagement Solutions Market, By Type of Solutions (Services, Patient Portals, and Others), By Delivery Mode, By Component, By Functionality, By Application, By End-Use, By Therapeutic Area, and By Region Forecast to 2032

Molecular Diagnostics Point of Care Market By Test Location (PoC, OTC), By Technology (PCR-based, Hybridization-based, Others), By Application (Oncology, Hematology, Others) and By End-Use (Decentralized Labs, Hospitals, Others), Forecasts to 2027

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: https://www.emergenresearch.com/

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Explore Our Japanese Version: Medical Devices Testing Market

Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights

Read our Press Release @ https://www.emergenresearch.com/press-release/global-medical-devices-testing-services-market

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.